Pharmacogenetics of human cytosolic sulfotransferases.
paper
Cited
Public
Unavailable
- Authors
- Nowell, S; Falany, C N
- Year
- 2006
- Journal
- Oncogene
- PMID
- 16550167
- DOI
- 10.1038/sj.onc.1209376
Cytosolic sulfotransferases (SULTs) are phase II detoxification enzymes that are involved in the biotransformation of a wide variety of structurally diverse endo- and xenobiotics, including many therapeutic agents and endogenous steroids. Single-nucleotide polymorphisms (SNPs) in SULTs have functional consequences on the translated protein. For the most part, these SNPs are fairly uncommon in the population, but some, most notably for SULT isoform 1A1, are commonly found and have been associated with cancer risk for a variety of tumor sites and also with response to therapeutic agents. SNPs in the hydroxysteroid sulfotransferase, SULT2A1, have been identified in African-American subjects and influence the ratio of plasma DHEA:DHEA-S. This modification could potentially influence cancer risk in steroidogenic tissues. SNPs in many SULTs are ethnically distributed, another factor that could influence SULT pharmacogenetics. Finally, genetic variation has also been identified in 3'-phosphoadenoside 5'-phosphosulfate synthetase (PAPPS), the enzymes responsible for producing the obligatory cosubstrate for all sulfotransferases. Taken together, this variability could substantially influence the disposition of drugs metabolized by SULTs. Elucidation of the basis and effect of variability in sulfation could greatly impact individualized therapy in the future.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases. | 2021 | 34417470 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alkaline mineral complex water protects piglets against viral infection by driving cholesterol consumption through the GPAT2/SULT2A1 axis. | Yao X et al. | β | 2026 | β |
| Python metabolomics uncovers a conserved postprandial metabolite and gut-brain feeding pathway. | Xiao S et al. | β | 2026 | β |
| SULT1E1 suppresses hepatocellular carcinoma progression via activation of the TGF-Ξ²/SMAD signaling pathway and cell cycle arrest. | Zhang W et al. | β | 2026 | β |
| Cholesterol Sulfate: Pathophysiological Implications and Potential Therapeutics. | Yu X et al. | β | 2025 | β |
| A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy. | Singh N et al. | β | 2024 | β |
| Complex roles for sulfation in the toxicities of polychlorinated biphenyls. | Duffel MW et al. | β | 2024 | β |
| Transcriptomics and Metabolomics Reveal Tomato Consumption Alters Hepatic Xenobiotic Metabolism and Induces Steroidal Alkaloid Metabolite Accumulation in Mice. | Dzakovich MP et al. | β | 2024 | β |
| Analysis of evolutionary and functional features of the bullfrog SULT1 family. | Sato K et al. | β | 2023 | β |
| Interactions of Betel Quid Constituents with Drug Disposition Pathways: An Overview. | Canlas J et al. | β | 2023 | β |
| 2-Naphthalenemethanol participates in metabolic activation of 2-methylnaphthalene. | Li K et al. | β | 2022 | β |
| Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application. | Gessner L et al. | β | 2022 | β |
| Pharmacogenetics of Drugs Used in the Treatment of Cancers. | Franczyk B et al. | β | 2022 | β |
| Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism. | Isvoran A et al. | β | 2022 | β |
| Unravelling sex-specific BPA toxicokinetics in children using a pediatric PBPK model. | Deepika D et al. | β | 2022 | β |
| A simple method to measure sulfonation in man using paracetamol as probe drug. | Marto N et al. | β | 2021 | β |
| Cholesterol and oxysterol sulfates: Pathophysiological roles and analytical challenges. | Sanchez LD et al. | β | 2021 | β |
| Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer. | Helland T et al. | β | 2021 | β |
| Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China. | Wang Y et al. | β | 2021 | β |
| Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases. | Kapoor M et al. | β | 2021 | β |
| Small-molecule control of neurotransmitter sulfonation. | Cook I et al. | β | 2021 | β |
| SULT genetic polymorphisms: physiological, pharmacological and clinical implications. | Kurogi K et al. | β | 2021 | β |
| Detection of clostebol in sports: Accidental doping? | de la Torre X et al. | β | 2020 | β |
| Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White? | De T et al. | β | 2019 | β |
| Effect of Environmental Exposure and Pharmacogenomics on Drug Metabolism. | Banerjee BD et al. | β | 2019 | β |
| Identification of equol-7-glucuronide-4'-sulfate, monoglucuronides and monosulfates in human plasma of 2 equol producers after administration of <i>kinako</i> by LC-ESI-MS. | Obara A et al. | β | 2019 | β |
| Isoform-specific therapeutic control of sulfonation in humans. | Cook I et al. | β | 2019 | β |
| Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism. | Ladumor MK et al. | β | 2019 | β |
| A high frequency missense SULT1B1 allelic variant (L145V) selectively expressed in African descendants exhibits altered kinetic properties. | Tibbs ZE et al. | β | 2018 | β |
| Effects of genetic polymorphisms on the sulfation of dehydroepiandrosterone and pregnenolone by human cytosolic sulfotransferase SULT2A1. | Abunnaja MS et al. | β | 2018 | β |
| Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy. | Sanchez-Spitman AB et al. | β | 2018 | β |
| Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. | Bessone F et al. | β | 2018 | β |
| Implications of sulfotransferase activity in interindividual variability in drug response: clinical perspective on current knowledge. | Marto N et al. | β | 2017 | β |
| New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens. | Gleicher N et al. | β | 2017 | β |
| Relationship of SULT1A1 copy number variation with estrogen metabolism and human health. | Liu J et al. | β | 2017 | β |
| SULT1A1 copy number variation: ethnic distribution analysis in an Indian population. | Almal S et al. | β | 2017 | β |
| Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation. | Cook I et al. | β | 2017 | β |
| The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. | Cassidy A et al. | β | 2017 | β |
| Associations between peripheral androgens and cortisol in infertile women. | Gleicher N et al. | β | 2016 | β |
| Controlling Sulfuryl-Transfer Biology. | Cook I et al. | β | 2016 | β |
| Design and Interpretation of Human Sulfotransferase 1A1 Assays. | Wang T et al. | β | 2016 | β |
| Detection and characterization of clostebol sulfate metabolites in Caucasian population. | Balcells G et al. | β | 2016 | β |
| Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1. | Wang T et al. | β | 2016 | β |
| Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer. | Leung AW et al. | β | 2016 | β |
| The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. | Gleicher N et al. | β | 2016 | β |
| The structure of the catechin-binding site of human sulfotransferase 1A1. | Cook I et al. | β | 2016 | β |
| Genetics of androgen metabolism in women with infertility and hypoandrogenism. | Shohat-Tal A et al. | β | 2015 | β |
| Mechanism of sulfotransferase pharmacogenetics in altered xenobiotic metabolism. | Chen BH et al. | β | 2015 | β |
| Sulfation of melatonin: enzymatic characterization, differences of organs, species and genders, and bioactivity variation. | Tian X et al. | β | 2015 | β |
| The allosteric binding sites of sulfotransferase 1A1. | Cook I et al. | β | 2015 | β |
| 3'-Phosphoadenosine 5'-phosphosulfate allosterically regulates sulfotransferase turnover. | Wang T et al. | β | 2014 | β |
| Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions. | Turcu A et al. | β | 2014 | β |
| Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells. | Rondini EA et al. | β | 2014 | β |
| The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. | Heger M et al. | β | 2014 | β |
| The role of drug metabolizing enzymes in clearance. | Di L | β | 2014 | β |
| Clinical effects of A4889G and T6235C polymorphisms in cytochrome P-450 CYP1A1 for breast cancer patients treated with tamoxifen: implications for tumor aggressiveness and patient survival. | Cardoso-Filho C et al. | β | 2013 | β |
| High accuracy in silico sulfotransferase models. | Cook I et al. | β | 2013 | β |
| Isoflavone metabolism in domestic cats (Felis catus): comparison of plasma metabolites detected after ingestion of two different dietary forms of genistein and daidzein. | Whitehouse-Tedd KM et al. | β | 2013 | β |
| Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia. | Perez-Sepulveda A et al. | β | 2013 | β |
| Methamphetamine regulation of sulfotransferase 1A1 and 2A1 expression in rat brain sections. | Zhou T et al. | β | 2013 | β |
| Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. | Innocenti F et al. | β | 2013 | β |
| Structure, dynamics and selectivity in the sulfotransferase family. | Leyh TS et al. | β | 2013 | β |
| The gate that governs sulfotransferase selectivity. | Cook I et al. | β | 2013 | β |
| Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. | Wallace BD et al. | β | 2013 | β |
| Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier. | Ho HT et al. | β | 2012 | β |
| Golgi-resident PAP-specific 3'-phosphatase-coupled sulfotransferase assays. | Prather B et al. | β | 2012 | β |
| Human PAPS synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm. | SchrΓΆder E et al. | β | 2012 | β |
| Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways. | Jiang W et al. | β | 2012 | β |
| SULT1A1 Arg213His polymorphism, smoked meat, and breast cancer risk: a case-control study and meta-analysis. | Lee H et al. | β | 2012 | β |
| SULT1A1 genetic polymorphisms and the association between smoking and oral cancer in a case-control study in Brazil. | Santos SS et al. | β | 2012 | β |
| Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. | Chitchumroonchokchai C et al. | β | 2012 | β |
| Drug metabolism alterations in nonalcoholic fatty liver disease. | Merrell MD et al. | β | 2011 | β |
| Gene coexpression network topology of cardiac development, hypertrophy, and failure. | Dewey FE et al. | β | 2011 | β |
| Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. | Turesky RJ et al. | β | 2011 | β |
| Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy. | Li J et al. | β | 2011 | β |
| The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. | Miller WL et al. | β | 2011 | β |
| A versatile polyacrylamide gel electrophoresis based sulfotransferase assay. | Wu ZL et al. | β | 2010 | β |
| Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs. | Fischer JJ et al. | β | 2010 | β |
| Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis. | Mercer KE et al. | β | 2010 | β |
| From sequence and structure of sulfotransferases and dihydropyrimidinases to an understanding of their mechanisms of action and function. | Hsu CC et al. | β | 2010 | β |
| Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment. | Ginsberg G et al. | β | 2010 | β |
| Glucocorticoids stimulate hepatic and renal catecholamine inactivation by direct rapid induction of the dopamine sulfotransferase Sult1d1. | Wong S et al. | β | 2010 | β |
| Identification of novel metoclopramide metabolites in humans: in vitro and in vivo studies. | Argikar UA et al. | β | 2010 | β |
| Phenotype prediction of nonsynonymous single nucleotide polymorphisms in human phase II drug/xenobiotic metabolizing enzymes: perspectives on molecular evolution. | Hao D et al. | β | 2010 | β |
| The Impact of CYP2D6 Genotyping on Tamoxifen Treatment. | Ferraldeschi R et al. | β | 2010 | β |
| The loss of phenol sulfotransferase 1 in hepatocellular carcinogenesis. | Yeo M et al. | β | 2010 | β |
| Androgen synthesis in adrenarche. | Miller WL | β | 2009 | β |
| Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer. | DezentjΓ© VO et al. | β | 2009 | β |
| Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1. | Mitchell DJ et al. | β | 2009 | β |
| Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells. | Pall M et al. | β | 2009 | β |
| Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. | Salman ED et al. | β | 2009 | β |
| Interindividual differences in response to plant-based diets: implications for cancer risk. | Lampe JW | β | 2009 | β |
| Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users. | DieudonnΓ© AS et al. | β | 2009 | β |
| Expression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder. | Svoboda M et al. | β | 2008 | β |
| Gene polymorphisms in bladder cancer. | Franekova M et al. | β | 2008 | β |
| Genetic polymorphism of sulfotransferase 1A1, cigarette smoking, hazardous chemical exposure and urothelial cancer risk in a Taiwanese population. | Wang YH et al. | β | 2008 | β |
| Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response? | Stearns V et al. | β | 2008 | β |
| Pharmacogenomics: a tool for improving cancer chemotherapy. | MonzΓ³ M et al. | β | 2008 | β |
| PhRMA white paper on ADME pharmacogenomics. | Williams JA et al. | β | 2008 | β |
| Sulfotransferase gene copy number variation: pharmacogenetics and function. | Hebbring SJ et al. | β | 2008 | β |
| Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy. | Bowen JM et al. | β | 2007 | β |
| Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. | Goodarzi MO et al. | β | 2007 | β |
| Interindividual differences in phytochemical metabolism and disposition. | Lampe JW et al. | β | 2007 | β |
| Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. | RouprΓͺt M et al. | β | 2007 | β |
| The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. | Nebert DW et al. | β | 2006 | β |